Debio 0932 yl-1 3 6-trihydroxy-9 10-anthraquinone-3-O-α-rhamnosyl-(1→2)-β-D-glucoside 35)21-8-6-7-19(14-21)23-15-22(28(33)30-20-9-11-32(4)12-10-20)18(3)26-25(23)24-13-17(2)16-29-27(24)31-26/h6-8

35)21-8-6-7-19(14-21)23-15-22(28(33)30-20-9-11-32(4)12-10-20)18(3)26-25(23)24-13-17(2)16-29-27(24)31-26/h6-8

InChi: InChI=1S/C15H13NO5/c1-9-3-5-10(6-4-9)14(17)11-7-12(16(19)20)15(18)13(8-11)21-2/h3-8

Balsalazide sodium hydrate could suppress colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway

InChi: InChI=1S/C22H28N4O6

Debio 0932 yl-1 3 6-trihydroxy-9 10-anthraquinone-3-O-α-rhamnosyl-(1→2)-β-D-glucoside 35)21-8-6-7-19(14-21)23-15-22(28(33)30-20-9-11-32(4)12-10-20)18(3)26-25(23)24-13-17(2)16-29-27(24)31-26/h6-8Debio 0932 (CUDC 305) is an orally active HSP90 inhibitor, with IC50s of 100 and 103 nM for HSP90 and HSP90, respectively. Product information CAS Number: 1061318 81 7 Molecular Weight: 442. 58 Formula: C22H30N6O2S Chemical Name: 2 {[6 (dimethylamino) 2H 1,3 benzodioxol 5 yl]sulfanyl} 1 {2 [(2,2 dimethylpropyl)amino]ethyl} 1H imidazo[4,5 c]pyridin 4 amine Smiles: CN(C)C1C=C2OCOC2=CC=1SC1=NC2C(N)=NC=CC=2N1CCNCC(C)(C)C InChiKey: RVJIQAYFTOPTKK